Indian Industry Divided Over Review of 86 Patents
March 20, 2009, SCRIP


A recent request by Indian companies seeking the reexamination of 86 local patents for reasons such as inadequate scrutiny has evoked strong reactions across industry.
The Organisation of Pharmaceutical Producers of India (OPPI), which represents multinational companies, said that India’s existing patent system offers adequate opportunity to challenge patents that have allegedly been granted wrongly. “After publication of the patent applied for in the patent journal, one can file a pre-grant opposition. Assuming someone has missed this opportunity, the provision for filing post grant opposition will still be there”, Tapan Ray, Director General of OPPI, told Scrip.